Immutep Limited Employee Directory

Biotechnology ResearchAustralia51-200 Employees

Immutep is a late-stage biotechnology company developing novel immunotherapies for cancer and autoimmune disease. The Company is a pioneer in the understanding and advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), and its diversified product portfolio harnesses LAG-3’s ability to stimulate or suppress the immune response. Immutep is dedicated to leveraging its expertise to bring innovative treatment options to patients in need and to maximise value for shareholders. Its lead clinical candidate in oncology is eftilagimod alfa, a proprietary soluble LAG-3 protein and MHC Class II agonist that activates the immune system to fight cancer. In autoimmune diseases, Immutep's IMP761 is the world's first LAG-3 agonist antibody designed to target the underlying causes of autoimmune diseases. Immutep is listed on the Australian Securities Exchange (IMM), and on the NASDAQ (IMMP) in the United States. For more information, please visit www.immutep.com.

Find Immutep Limited employees' phone numbers or email addresses

Immutep Limited Global Highlights

Europe
33

Germany
19
France
6
Hungary
4
Netherlands
2
Poland
1
United Kingdom Of Great Britain And Northern Ireland
1

Oceania
11

Australia
11

North America
2

United States Of America
1
Mexico
1

Africa
1

Niger
1

Asia
1

India
1

Immutep Limited's Leadership

S. W.
Chief Medical Officer
Mobile Phone
Email
F. T.
Chief Scientific Officer
Mobile Phone
Email
C. J.
Vice President Manufacturing
Mobile Phone
Email
M. V.
Ceo
Mobile Phone
Email
R. J. H.
Chairman Of The Board
Mobile Phone
Email
F. T.
Cso And Cmo
Mobile Phone
Email
M. V.
Cfo
Mobile Phone
Email
C. B.
Vice President, Investor Relations And Corporate Communications
Mobile Phone
Email

Contact profiles from Immutep Limited

Name

Title

Contact Info

Location

Last Update

E. S.
Regulatory Affairs Manager
Mobile Phone
Email
GermanyBerlin
Oct 26, 2025
D. M.
General Counsel & Company Secretary
Mobile Phone
Email
AustraliaNew South Wales
Oct 29, 2025
A. L. P.
R&d Scientist In Immunology (inflammation And Immuno-Oncology)
Mobile Phone
Email
France
Nov 03, 2025
M. B.
Cadre De Recherche En Immunologie Cellulaire
Mobile Phone
Email
FranceÎle-de-France
Jul 17, 2025
M. K.
Clinical Trial Associate
Mobile Phone
Email
GermanyBerlin
Jul 18, 2025
S. P.
Clinical Research Scientist
Mobile Phone
Email
GermanyBerlin
Oct 24, 2025
B. W.
Consultant
Mobile Phone
Email
United StatesOregon
Apr 27, 2025
T. A.
Ingénieure R&d En Immunologie
Mobile Phone
Email
FranceÎle-de-France
Oct 23, 2025

Frequently Asked Questions

What is Immutep Limited known for?

Immutep Limited operates in the Biotechnology Research industry. The company's main headquarters is located in Level 33, Australia Square 264 George Street, Sydney, NSW 2000, AU. Explore Immutep Limited's company overview page for more information.

What is Immutep Limited's most common email format?

Immutep Limited employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Immutep Limited email formats with LeadIQ.

How many employees does Immutep Limited have currently?

Immutep Limited has approximately 54 employees as of October 2025. These team members are located across 5 continents, including EuropeOceaniaNorth America.

Who are Immutep Limited's key employees and leadership?

As of October 2025, Immutep Limited's key employees include:

Chief Medical Officer: S. W.
Chief Scientific Officer: F. T.
Vice President Manufacturing: C. J.
Ceo: M. V.
Chairman Of The Board: R. J. H.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking